234 related articles for article (PubMed ID: 11885931)
1. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
[TBL] [Abstract][Full Text] [Related]
2. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
3. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.
Hebben M; Brants J; Birck C; Samama JP; Wasylyk B; Spehner D; Pradeau K; Domi A; Moss B; Schultz P; Drillien R
Protein Expr Purif; 2007 Dec; 56(2):269-78. PubMed ID: 17892951
[TBL] [Abstract][Full Text] [Related]
4. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
Ferrer MF; Zanetti FA; Calamante G
Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
[TBL] [Abstract][Full Text] [Related]
5. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara.
Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R
Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873
[TBL] [Abstract][Full Text] [Related]
6. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Wyatt LS; Moss B; Rozenblatt S
Virology; 1995 Jun; 210(1):202-5. PubMed ID: 7793072
[TBL] [Abstract][Full Text] [Related]
7. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
Ramsey-Ewing A; Moss B
Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
[TBL] [Abstract][Full Text] [Related]
8. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
[TBL] [Abstract][Full Text] [Related]
9. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters].
Loparev VN; Chernos VI
Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696
[TBL] [Abstract][Full Text] [Related]
10. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
11. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
Sutter G; Ohlmann M; Erfle V
FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
[TBL] [Abstract][Full Text] [Related]
12. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain.
Spehner D; Drillien R; Proamer F; Houssais-Pêcheur C; Zanta MA; Geist M; Dott K; Balloul JM
Virology; 2000 Jul; 273(1):9-15. PubMed ID: 10891402
[TBL] [Abstract][Full Text] [Related]
13. [Expression of IL-6 in recombinant non-replicating vaccinia virus and studying its effects on immunogenicity].
Guo F; Lu R; Sun Z; Ma H; Li J; Zhang Y; Ma D; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):136-41. PubMed ID: 12196824
[TBL] [Abstract][Full Text] [Related]
14. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of replication-deficient vaccinia virus/T7 RNA polymerase hybrid expression: effect of T7 RNA polymerase levels and alpha-amanitin.
Engleka KA; Lewis EW; Howard BH
Virology; 1998 Apr; 243(2):331-9. PubMed ID: 9568032
[TBL] [Abstract][Full Text] [Related]
16. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter G; Moss B
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
[TBL] [Abstract][Full Text] [Related]
17. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P
Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582
[TBL] [Abstract][Full Text] [Related]
18. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture.
Bárcena J; Blasco R
Virology; 1998 Apr; 243(2):396-405. PubMed ID: 9568038
[TBL] [Abstract][Full Text] [Related]
19. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
[TBL] [Abstract][Full Text] [Related]
20. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
